Coffee (KC)

Kingsoft Cloud Holdings 株価情報 (NASDAQ: KC)

最新ニュース Kingsoft Cloud Holdings (NASDAQ:KC) 株価情報

Kingsoft Cloud Hldgs

Kingsoft Cloud Holdings

Kingsoft Cloud Holdings Ltd is an independent cloud service provider in China. It provides integrated cloud-based services including cloud computing, storage, and delivery. Its products and services are Security, Database, Data Analysis, Networking, and others. Its solutions are medical, government affairs, finance, media, education, gaming, Vehicle solutions, and others.

Kingsoft Cloud Holdings Limited - American Depositary Shares

Kingsoft Cloud Holdings Ltd

KraneShares Trust KraneShares China Alpha Index ETF

Series Portfolio Trust Subversive Food Security ETF

KraneShares California Carbon Allowance Strategy ETF

KUTCHO COPPER CORP ORD by Kutcho Copper Corp.

Kutcho Copper Corp

KCCPAD

KIMBERLY-CLARK DE MEX A by Kimberly-Clark de Mexico, S.A.B de C.V.

Kimberly - Clark de Mexico SAB de CV

KIMBERLY-CLARK MEX S/ADR by Kimberly-Clark de Mexico, S.A.B de C.V.

SPDR S&P Capital Markets ETF

KCE ELECTRONICS PUB ADR by KCE Electronics Pub Co Ltd.

KCE Electronics PCL

KENSINGTON CAPITAL ACQUISITION CORP V ORD

KUMIAI CHEMICAL INDS by Kumiai Chemical Industry Co., Ltd.

Kumiai Chemical Industry Co Ltd

KECK SENG INVESTMENTS by Keck Seng Investments

Keck Seng Investments (Hong Kong) Ltd

KINGSOFT CLOUD HLDGS LTD by Kingsoft Cloud Holdings Limited

KANSAS CITY LIFE INS NEW by Kansas City Life Insurance Co.

Kansas City Life Insurance Co

KCM Holdings Corp

KEY CAPITAL CORP by Key Capital Corporation

Key Capital Corp

Kindcard Inc

KuCoin Token

KraneShares Trust KraneShares Sustainable Ultra Short Duration Index ETF

<h3>Gainers</h3>
<ul>
<li>Ekso Bionics Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) shares increased by 85.4% to $0.84 during Thursday's pre-market session. The company's market cap stands at $20.8 million. </li>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares moved upwards by 43.64% to $0.05. </li>
<li>Aytu BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) shares rose 40.74% to $1.9. The market value of their outstanding shares is at $11.7 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Abpro Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABP#NASDAQ">ABP</a>) stock rose 35.69% to $0.22. The company's market cap stands at $11.6 million. </li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) stock rose 22.33% to $8.6. The company's market cap stands at $377.4 million. </li>
<li>Oncology Institute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOI#NASDAQ">TOI</a>) stock increased by 20.25% to $2.85. The company's market cap stands at $250.1 million. As per the press release, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock fell 82.1% to $0.04 during Thursday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock declined by 37.35% to $0.18. The market value of their outstanding shares is at $5.1 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) stock fell 24.51% to $0.17. The market value of their outstanding shares is at $24.1 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>IN8bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INAB#NASDAQ">INAB</a>) shares declined by 20.66% to $0.12. The company's market cap stands at $10.5 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) stock declined by 20.16% to $3.05. The company's market cap stands at $2.5 million. </li>
<li>Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) shares decreased by 16.96% to $0.69. The company's market cap stands at $83.2 million. As per the press release, Q1 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AYTU

BDSX

EKSO

HCTI

INAB

IVVD

KLTO

NAOV

NCNA

NNNN

12 Health Care Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares rose 226.7% to $0.91 during Thursday's pre-market session. The market value of their outstanding shares is at $28.9 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) stock increased by 115.56% to $0.21. The company's market cap stands at $30.6 million. </li>
<li>Innovative Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISSC#NASDAQ">ISSC</a>) stock rose 27.39% to $9.36. The market value of their outstanding shares is at $164.2 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>NV5 Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEE#NASDAQ">NVEE</a>) shares rose 16.65% to $21.99. The company's market cap stands at $1.4 billion. </li>
<li>Acuren (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/TIC#AMEX">TIC</a>) stock moved upwards by 13.43% to $11.99. The company's market cap stands at $1.4 billion. </li>
<li>Urban-gro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares moved upwards by 9.33% to $0.43. The market value of their outstanding shares is at $5.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Primega Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGHL#NASDAQ">PGHL</a>) shares fell 29.3% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $18.5 million. </li>
<li>High-Trend International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) stock decreased by 19.13% to $0.32. The market value of their outstanding shares is at $39.1 million. </li>
<li>Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) stock decreased by 16.69% to $5.09. The market value of their outstanding shares is at $850.9 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) shares decreased by 14.02% to $0.22. The company's market cap stands at $4.6 million. </li>
<li>T1 Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TE#NYSE">TE</a>) shares declined by 13.55% to $1.34. The company's market cap stands at $188.0 million. As per the news, the Q1 earnings report came out today. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) stock fell 10.89% to $0.25. The company's market cap stands at $7.4 million. As per the press release, Q1 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

HTCO

ISSC

NVEE

PGHL

SHLS

UGRO

WATT

WLGS

12 Industrials Stocks Moving In Thursday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) stock moved upwards by 15.1% to $0.91 during Thursday's pre-market session. The company's market cap stands at $171.2 million. </li>
<li>Sigmatron Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMA#NASDAQ">SGMA</a>) stock increased by 11.37% to $1.57. The company's market cap stands at $9.6 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock increased by 10.31% to $1.14. The market value of their outstanding shares is at $8.0 million. </li>
<li>MagnaChip Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MX#NYSE">MX</a>) shares moved upwards by 6.84% to $3.9. The company's market cap stands at $140.6 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>U-BX Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) shares rose 6.48% to $4.6. The company's market cap stands at $95.6 million. </li>
<li>Nvni Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVNI#NASDAQ">NVNI</a>) shares moved upwards by 6.08% to $0.42. The market value of their outstanding shares is at $39.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Intchains Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICG#NASDAQ">ICG</a>) shares fell 20.6% to $2.08 during Thursday's pre-market session. The company's market cap stands at $125.5 million. </li>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock declined by 18.04% to $1.5. </li>
<li>DXC Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) stock fell 13.95% to $14.25. The company's market cap stands at $2.5 billion. The company's, Q4 earnings came out yesterday. </li>
<li>Red Cat Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock fell 12.64% to $5.81. The company's market cap stands at $525.8 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) stock decreased by 9.81% to $0.92. The company's market cap stands at $96.9 million. The company's, Q1 earnings came out yesterday. </li>
<li>Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) stock fell 9.32% to $0.55. The company's market cap stands at $10.3 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MOVE

NVNI

RCAT

REKR

SGMA

SMRT

SVRE

UBXG

12 Information Technology Stocks Moving In Thursday's Pre-Market Session

Synergy CHC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNYR#NASDAQ">SNYR</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. The company reported quarterly sales of $8.17 million.

Earnings

Earnings Beats

News

SNYR

Synergy CHC Q1 EPS $0.10 Beats $0.07 Estimate, Sales $8.17M Lower Than $9.41M YoY

Chardan Capital analyst Geulah Livshits maintains Metagenomi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGX#NASDAQ">MGX</a>) with a Buy and lowers the price target from $13 to $12.

Price Target

Analyst Ratings

Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12

Biotech

General

IMNN

IMUNON Announces Six-Month Data From Phase 1 Proof-Of-Concept Trial Of Its IMNN-101 NA Vaccine Platform; Says Its PlaCCine Platform 'demonstrates better durability and other advantages compared to mRNA vaccines'

Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) announced on Wednesday that it has been chosen by <a href="https://www.benzinga.com/pressreleases/25/05/b45420724/rocket-lab-to-launch-nasa-astrophysics-science-mission-on-electron-to-study-galaxy-evolution" target="_blank" rel="noreferrer noopener">NASA </a><a href="https://www.benzinga.com/pressreleases/25/05/b45420724/rocket-lab-to-launch-nasa-astrophysics-science-mission-on-electron-to-study-galaxy-evolution" target="_blank" rel="noreferrer noopener">to launch its Aspera mission</a>.
Aspera is an astrophysics science mission designed to study the formation and evolution of galaxies and provide new insights into how the universe works.
NASA selected Rocket Lab to launch its Aspera astrophysics mission (studying galaxy formation via UV light) on Electron from Launch Complex 1, targeting no earlier than the first quarter of 2026.
Also Read: <a target="_blank" href="https://www.benzinga.com/content/45012021/rocket-lab-lands-new-contract-builds-momentum-ahead-of-earnings" rel="noreferrer noopener">Rocket Lab Lands New Contract, Builds Momentum Ahead of Earnings</a>
Aspera will utilize a telescope to observe ultraviolet light, studying the hot gas known as the intergalactic medium that exists between galaxies and is believed to play a role in the formation of stars and planets.
This mission will be the first NASA astrophysics endeavor to collect and map these ultraviolet light signatures, potentially revealing deeper insights into the origins of stars, planets, and life in the universe.
Rocket Lab founder and CEO Sir Peter Beck stated, &#8220;As a long trusted launch partner for NASA&#8217;s most pioneering small satellites, it&#8217;s great to be able to continue that support for another innovative science mission like Aspera. Electron has proven itself to be the premier small launcher through complete launch schedule control and reliably accurate orbital deployment, and we&#8217;re looking forward to delivering that again for Aspera.&#8221;
In a separate release, Rocket Lab announced that its Pioneer spacecraft&nbsp;made a successful return to Earth on Wednesday, marking the company&#8217;s second Earth return mission in two months. Varda&#8217;s W-3 mission launched <a target="_blank" href="https://www.benzinga.com/25/05/45414422/rocket-lab-stock-is-rallying-wednesday-whats-going-on" rel="noreferrer noopener">15 days after the return of W-2</a>.
Last week, the company&nbsp;reported financial results for the first quarter, with revenues of $122.57 million, beating the&nbsp;consensus&nbsp;estimate of $121.38 million and loss of 12 cents per share, beating analyst estimates <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45327779/rocket-labs-new-defense-deal-2025-forecast-win-analyst-support" rel="noreferrer noopener">of 13 cents loss per share</a>.
Investors can gain exposure to the stock via&nbsp;ARK Space Exploration &amp; Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>) and Procure Space ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFO#NASDAQ">UFO</a>).
Price Action: RKLB shares are down 2.40% at $23.55 premarket at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com//node/45143330" target="_blank" rel="noreferrer noopener">AI, Hypersonics,&nbsp;$24 Billion&nbsp;Market: Portfolio Manager Gives A Peek Inside GCAD&#8217;s Bet On Drone Warfare Dominance</a></li>
</ul>
Image by Emagnetic via Shutterstock

Equities

Large Cap

Contracts

ARKX

RKLB

Rocket Lab Gets NASA Contract To Launch Aspera Astrophysics Mission

<ul>
<li>Blue Owl Digital Infrastructure Fund III seeks to support the global capital demands of&nbsp;hyperscalers, fueled by ongoing investments in data centers and artificial intelligence.</li>
</ul>
NEW YORK, May 15, 2025 /PRNewswire/ -- Blue Owl Capital Inc. ("Blue Owl") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OWL#NYSE">OWL</a>), a leading alternative asset manager, announced today the final close of its most recent digital infrastructure fund, Blue Owl Digital Infrastructure Fund III ("ODI III") with $7 billion of total capital commitments. ODI III exceeded the original target of $4 billion and hit its hard cap.
ODI III will focus on developing, acquiring, and owning data centers and other connectivity related real assets to help meet the AI and cloud-driven global digital capacity needs of the world's largest technology companies, with a focus on large-scale, build-to-suit developments.

Blue Owl Closes $7B Digital Infrastructure Fund III To Support Hyperscaler Demand Amid AI And Cloud Boom, Surpassing $4B Target To Invest In Data Centers And Connectivity Assets Worldwide

<a href="https://www.globenewswire.com/Tracker?data=1Cv5vc6xPugdycgEI5g5MdjtOphqPViQBh2de9Wew2xQaCN7hVFga3quhCMOlC-V5wWvMzxJvQZavTaoOXF6bg==">Merus N.V.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRUS#NASDAQ">MRUS</a>) ("Merus", "the Company", "we", or "our"), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics&#xAE;, Triclonics&#xAE; and ADClonics&#xAE;), today announced publication on the mechanism of action of petosemtamab, a bispecific antibody targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G (LGR5), in the scientific journal "Cancers", a MDPI publication, available <a href="https://www.globenewswire.com/Tracker?data=qDy227Jlbf1q1FH5Gxy-pD1yN8G32hMajPBa7ZAAO61n2po-XuClGyspYfkeqMv_Yt_DqAC3_Jcym2YqyszV_3-VsruA190TW6MqqQ6agkc=">here</a>.

MRUS

Merus Announces Publication On Mechanism Of Action Of Petosemtamab, Bispecific Antibody Targeting EGFR And LGR5, In Scientific Journal "Cancers"

WIIM

Youdao shares are trading higher after the company reported a year-over-year increase in Q1 EPS results.

HC Wainwright &amp; Co. analyst Sean Lee reiterates CytoSorbents (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) with a Neutral and maintains $1 price target.

Reiteration

CTSO

HC Wainwright & Co. Reiterates Neutral on CytoSorbents, Maintains $1 Price Target

Acuren shares are trading higher after the company announced a merger with NV. Also, the company announced it has been approved for uplisting to the NYSE.

IM Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) reported quarterly earnings of $0.06 per share. This is a 103.23 percent increase over losses of $(1.86) per share from the same period last year. The company reported $8.71 million in sales this quarter. This is a 2.69 percent decrease over sales of $8.95 million the same period last year.

IMCC

IM Cannabis Q1 EPS $0.06 Up From $(1.86) YoY, Sales $8.71M Down From $8.95M YoY

CGNX

IMA E-COMMERCE Enhances Order Fulfillment Efficiency And Sustainability With Cognex's Advanced In-Sight Vision Systems And DataMan Barcode Readers

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>JP Morgan analyst Samik Chatterjee downgraded the rating for Luminar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) from Overweight to Neutral. Luminar shares closed at $4.76 on Wednesday. <a href="https://www.benzinga.com/quote/lazr/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Scotiabank analyst Greg McGinniss downgraded Americold Realty Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COLD#NYSE">COLD</a>) from Sector Outperform to Sector Perform and announced a $20 price target. Americold Realty Trust shares closed at $17.94 on Wednesday. <a href="https://www.benzinga.com/quote/cold/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Daniel Major downgraded the rating for Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) from Buy to Neutral and announced a $31 price target. Alcoa shares closed at $29.61 on Wednesday. <a href="https://www.benzinga.com/quote/aa/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Sami Corwin downgraded the rating for Nkarta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTX#NASDAQ">NKTX</a>) from Outperform to Market Perform. Nkarta shares closed at $1.87 on Wednesday. <a href="https://www.benzinga.com/quote/NKTX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Telsey Advisory Group analyst Dana Telsey downgraded Grove Collaborative Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROV#NYSE">GROV</a>) from Outperform to Market Perform and slashed the price target from $2 to $1.2. Grove Collaborative shares closed at $1.19 on Wednesday. <a href="https://www.benzinga.com/quote/GROV/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying AA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="575" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179-1024x575.png" alt="" class="wp-image-916381" style="width:623px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179-1024x575.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179-768x431.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15080300/image-179.png 1125w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45405004/jim-cramer-sofi-goes-to-new-highs-recommends-not-buying-this-health-care-stock">Jim Cramer: SoFi Goes To &#8216;New Highs,&#8217; Recommends Not Buying This Health Care Stock</a> </li>
</ul>
Photo via Shutterstock

Downgrades

Pre-Market Outlook

Trading Ideas

COLD

GROV

LAZR

NKTX

This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Fiscal 2025 Guidance
The Company is updating its expectations for fiscal 2025 revenue to be in the range of $29.0 to $31.0 million. The change in expectations is primarily due to expected continuing disruptions within the U.S. sorghum market due to decreased exports by customers to China and general market uncertainty. In fiscal 2024, comparable revenue from continuing operations was $38.0 million, which excludes revenue generated by the Company's former Australian subsidiary.&nbsp;
The Company now expects Adjusted EBITDA to be in the range of ($8.5) to ($7.0) million for fiscal 2025.

Guidance

SANW

S&W Seed Lowers FY2025 Sales Guidance from $34.50M-$38.00M to $29.00M-$31.00M vs $35.89M Est

Lifeward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFWD#NASDAQ">LFWD</a>) affirms FY2025 sales outlook from $28.00 million-$30.00 million to $28.00 million-$30.00 million vs $28.98 million estimate.

LFWD

Lifeward Affirms FY2025 Sales Guidance of $28.00M-$30.00M vs $28.98M Est

S&amp;W Seed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.09) by 47.71 percent. This is a 68.16 percent increase over losses of $(1.79) per share from the same period last year. The company reported quarterly sales of $9.55 million which beat the analyst consensus estimate of $9.50 million by 0.53 percent. This is a 1.95 percent increase over sales of $9.37 million the same period last year.

S&W Seed Q3 Adj. EPS $(0.57) Beats $(1.09) Estimate, Sales $9.55M Beat $9.50M Estimate

Rewalk Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFWD#NASDAQ">LFWD</a>) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.38) by 15.79 percent. This is a 29.03 percent increase over losses of $(0.62) per share from the same period last year. The company reported quarterly sales of $5.03 million which missed the analyst consensus estimate of $5.75 million by 12.51 percent. This is a 4.71 percent decrease over sales of $5.28 million the same period last year.

Earnings Misses

Rewalk Robotics Q1 Adj. EPS $(0.44) Misses $(0.38) Estimate, Sales $5.03M Miss $5.75M Estimate

GSX Techedu Inc. American Depositary Shares

GOTU

Gaotu Techedu shares are trading higher after the company reported a year-over-year increase in Q1 sales results.

Press Releases

Kingsoft Cloud to Report Second Quarter 2024 Financial Results on August 20, 2024

Kingsoft Cloud Announces Unaudited Second Quarter 2024 Financial Results

Kingsoft Cloud to Report Third Quarter 2024 Financial Results on November 19, 2024

Kingsoft Cloud Announces Unaudited Third Quarter 2024 Financial Results with Accelerated Revenue Growth and Robust Expansion of Gross and EBITDA profit

Kingsoft Cloud to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025

Kingsoft Cloud Announces Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results; First Time Operating Margin Profitable with Accelerated Growing Revenue of AI Cloud

Comments

Kingsoft Cloud Holdings

ニュース

最新ニュース Kingsoft Cloud Holdings (NASDAQ:KC) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル